α-Lipoic acid treatment of 31 patients with sore, burning mouth

Oral Diseases

Volumn 14, Issue 6, 2008, Pages 529-532

  Steele, J C ^a   Bruce, A J ^a   Drage, L A ^a   Rogers III, R S ^a  

^a MAYO CLINIC   (United States)

Author keywords

lipoic acid; Burning mouth; Retrospective study

Indexed keywords

THIOCTIC ACID;

BURNING MOUTH SYNDROME; DYSPNEA; ECZEMA; FOLLOW UP; GASTRITIS; HEARTBURN; HUMAN; INTERVIEW; MEDICAL RECORD; MEDICAL RECORD REVIEW; MOUTH PAIN; MUSCLE CRAMP; NAUSEA; NAUSEA AND VOMITING; NEUROPATHY; OUTCOME ASSESSMENT; PARESTHESIA; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PURPURA; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; REVIEW; SYMPTOM; TELEPHONE; TENSION HEADACHE; TERTIARY HEALTH CARE; THROMBOCYTE ANOMALY; UNIVERSITY HOSPITAL; URTICARIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ATTITUDE TO HEALTH; BURNING MOUTH SYNDROME; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIP DISEASES; MALE; MIDDLE AGED; PALATE; PATIENT SATISFACTION; RETROSPECTIVE STUDIES; TASTE DISORDERS; THIOCTIC ACID; TONGUE DISEASES; TREATMENT OUTCOME; VITAMIN B COMPLEX; XEROSTOMIA;

EID: 49749147551     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2007.01414.x     Document Type: Review

References (15)

1. ® System [Internet database]. Thomson Micromedex : Greenwood Village, CO. http://www.micromedex.com [accessedon 24 May 2006].
2. Drage LA, Rogers RS, III. (1999). Clinical assessment and outcome in 70 patients with complaints of burning or sore mouth symptoms. Mayo Clin Proc 74 : 223 228.
3. Drage LA, Rogers RS, III. (2003). Burning mouth syndrome. Dermatol Clin 21 : 135 145.
4. Drage LA, Bruce AJ, Rogers RS, III. (2006). Glossodynia/burning mouth syndrome. In : Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I, eds. Treatment of skin disease: comprehensive therapeutic strategies. 2nd edn. Mosby Elsevier : Philadelphia, pp. 241 243.
5. Femiano F (2002). Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies. Minerva Stomatol 51 : 405 409.
6. Femiano F, Scully C (2002). Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 31 : 267 269.
7. Femiano F, Gombos F, Scully C, Busciolano M, De Luca P (2000). Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 6 : 274 277.
8. Femiano F, Scully C, Gombos F (2002). Idiopathic dysgeusia: an open trial of alpha lipoic acid (ALA) therapy. Int J Oral Maxillofac Surg 31 : 625 628.
9. Femiano F, Gombos F, Scully C (2004a). Burning mouth syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 9 : 8 13.
10. Femiano F, Gombos F, Scully C (2004b). Burning mouth syndrome: the efficacy of lipoic acid on subgroups. J Eur Acad Dermatol Venereol 18 : 676 678.
11. Sardella A, Lodi G, Demarosi F, Bez C, Cassano S, Carrassi A (2006). Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 12 : 152 155.
12. Sweetman S, ed. (updated periodically). Martindale: the complete drug reference. [Internet database]. Thomas Micromedex : Greenwood Village, CO. http://www.micromedex.com [accessedon 31 May 2006].
13. Tirosh O, Sen CK, Roy S, Kobayashi MS, Packer L (1999). Neuroprotective effects of alpha-lipoic acid and its positively charged amide analogue. Free Radic Biol Med 26 : 1418 1426.
14. Zakrzewska JM, Forssell H, Glenny AM (2005). Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev Jan 25; (1) : CD002779.
15. Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G (1997). Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients: a 4-month randomized controlled multicenter trial (DEKAN Study) Deutsche Kardiale Autonome Neuropathie. Diabetes Care 20 : 369 373.